189
Participants
Start Date
January 31, 2015
Primary Completion Date
September 30, 2018
Study Completion Date
September 25, 2018
Albendazole
"Subjects in Arms 1, 2, and 4 will receive 400mg of Albendazole~Subjects in Arm 3 will receive 800mg of Albendazole"
Ivermectin
Subjects in Arms 1 and 4 will receive 200mg/kg body weight
Diethylcarbamazine
Participants in Arm 4 will receive 6mg/kg of Diethylcarbamazine per body weight
Cote d'Ivoire, Abidjan
Washington University School of Medicine
OTHER
University Hospitals Cleveland Medical Center
OTHER